CROMA PhilArt EYE

INFORMATION

Product Description
CROMA PhilArt EYE Product Overview

CROMA PhilArt EYE is a polynucleotide-based injectable designed specifically for rejuvenating the eye contour area, including sensitive regions like the eyelids. Its primary component, PN-HPT® (Polynucleotide Highly Purified Technology), works to enhance collagen and elastin production, supporting improved skin elasticity, hydration, and texture. This biostimulating product is targeted at reducing fine lines and superficial wrinkles around the eyes, delivering a more youthful and radiant appearance. The product is recommended for individuals experiencing early signs of aging around the eye area​.

Key Features:

Active Ingredient: PN-HPT® 15 mg/2 ml
Application Areas: Eye contour, including eyelids and fine lines around the eyes
Mechanism: Stimulates collagen and elastin, increases hydration, and reduces fine lines
CROMA PhilArt EYE Indications for Use

PhilArt EYE is formulated to rejuvenate and hydrate the delicate skin around the eyes. It is indicated for treating early signs of aging, specifically targeting fine lines, wrinkles, and mild sagging in the periocular area. The product’s polynucleotide composition makes it suitable for patients seeking a natural enhancement for a refreshed appearance.

Primary Indications:

Fine Lines and Wrinkles: Smooths superficial lines around the eyes, including crow’s feet.
Hydration and Elasticity Improvement: Provides deep hydration, improving skin elasticity for a firmer look.
Eye Contour Revitalization: Brightens and refreshes the under-eye area, minimizing signs of tiredness and fatigue​.
CROMA PhilArt EYE Dosage Information

The recommended dosage and administration technique ensure optimal results and patient safety. PhilArt EYE is administered in specific areas around the eyes to maximize its biostimulating effects.

Treatment Protocol:

Dosage per Session: Each session uses 2 ml of PhilArt EYE solution, focusing on the targeted periocular areas.
Application Technique: Microinjections or a fine needle are used for even distribution of the product.
Frequency of Treatments: An initial series of 3 sessions is recommended, spaced 2-3 weeks apart for optimal rejuvenation.
Maintenance: For sustained results, maintenance sessions are recommended every 6-9 months​.
CROMA PhilArt EYE Side Effects and Precautions

PhilArt EYE has a high safety profile due to its biocompatible and purified polynucleotide formulation. However, minor side effects may occur, particularly in sensitive skin areas around the eyes.

Common Side Effects:

Redness and Swelling: Temporary swelling or mild redness at the injection sites, typically resolving within 24-48 hours.
Mild Itching or Tenderness: Some patients may experience slight discomfort or tenderness initially.
Transient Sensitivity: Sensitivity around the eyes may occur, especially during the first session.

Precautions:

Avoid in Infected Areas: Do not apply to areas with active infections or skin conditions.
Patch Test for Sensitive Skin: Perform a patch test on individuals with known sensitivities to polynucleotides.
Post-Treatment Care: Minimize exposure to direct sunlight and avoid intense physical activity for 24 hours post-treatment.
Pregnancy and Breastfeeding: Not recommended for use during pregnancy or breastfeeding due to insufficient safety data​.
CROMA PhilArt EYE Clinical Studies or Real-World Outcomes

PhilArt EYE has demonstrated significant efficacy in clinical and real-world settings, with improvements in skin texture, hydration, and elasticity around the eyes. Patients reported noticeable results, with high levels of satisfaction due to the product’s natural rejuvenating effect.

Key Findings:

Reduction in Fine Lines: Patients experienced a 25-35% reduction in fine lines around the eyes after a full treatment cycle.
Improvement in Skin Brightness: Clinical trials report enhanced brightness and reduced signs of tiredness in the eye area.
Patient Satisfaction: 90% of patients reported satisfaction with the results, noting a refreshed and youthful look.

Clinical Observations:

Hydration and Elasticity: Observed improvements in skin hydration and elasticity were sustained for up to 6 months following treatment.
Minimal Adverse Events: Side effects were minimal, with only minor redness or tenderness in the treated areas.
Enhanced Treatment Outcomes with Combination Therapy: When combined with other aesthetic treatments like microneedling or hyaluronic acid fillers, PhilArt EYE further boosted skin resilience and elasticity​.
CROMA PhilArt EYE Composition and Active Ingredients

PhilArt EYE contains PN-HPT®, a specialized formulation of polynucleotides derived from high-purity sources. This component is designed to support cellular regeneration and moisture retention in the skin, particularly beneficial for delicate areas like the eye contour.

Key Ingredients:

Polynucleotide (PN-HPT®) 15 mg/2 ml: Stimulates collagen and elastin synthesis, promoting a firm and hydrated appearance.
Biocompatible Formulation: Ensures minimal risk of adverse reactions while supporting dermal regeneration and repair in sensitive skin regions​.
CROMA PhilArt EYE Drug Interactions

As a topical injectable, PhilArt EYE remains localized to the treatment area with limited systemic effects, reducing the likelihood of drug interactions.

Important Considerations:

Combination with Other Aesthetic Treatments: Can be combined with procedures such as laser therapy, chemical peels, or hyaluronic acid injections with a one-week interval to prevent overstressing the skin.
Anticoagulants: Patients using blood thinners may experience increased bruising around injection sites.

Immunosuppressive Therapy: Caution is advised for patients on immunosuppressive medications due to potential variations in skin response​.